Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
7.54
+0.34 (4.72%)
At close: May 8, 2025, 4:00 PM
7.54
0.00 (0.00%)
After-hours: May 8, 2025, 4:00 PM EDT
Treace Medical Concepts Revenue
Treace Medical Concepts had revenue of $52.57M in the quarter ending March 31, 2025, with 2.86% growth. This brings the company's revenue in the last twelve months to $210.82M, up 7.54% year-over-year. In the year 2024, Treace Medical Concepts had annual revenue of $209.36M with 11.89% growth.
Revenue (ttm)
$210.82M
Revenue Growth
+7.54%
P/S Ratio
2.23
Revenue / Employee
$441,969
Employees
477
Market Cap
474.02M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TMCI News
- 2 days ago - Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI) - GlobeNewsWire
- 5 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - Accesswire
- 10 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI - GlobeNewsWire
- 14 days ago - Treace to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire
- 19 days ago - SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - Accesswire
- 5 weeks ago - Treace Announces Clinical Study Data Demonstrating Positive Lapiplasty® and Adductoplasty® Outcomes at the 2025 ACFAS Annual Scientific Conference - GlobeNewsWire
- 6 weeks ago - Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference - GlobeNewsWire
- 2 months ago - The Schall Law Firm Invites Investors With Losses In Treace Medical Concepts, Inc. To Join A Securities Fraud Investigation - Accesswire